Mustang Bio, Inc. (MBIO) stock
MBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.38−0.01 (-2.56%)
Close on Nov 18, 2026Market cap $2.88MP/E –Yield –
Earnings
Mustang Bio's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
–
Not yet scheduled
Revenue, Q3 FY2023
–
EPS, Q3 FY2023
-$1.23
-$0.18 a year earlier
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Mustang Bio's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q1 FY2024ended Mar 31, 2024 | Apr 29, 2024during market hours | – | – | – | Filing |
| Q4 FY2023ended Dec 31, 2023 | Mar 11, 2024after the close | – | – | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 14, 2023after the close | – | – | -$1.23 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 14, 2023after the close | – | – | – | Release |
| Q1 FY2023ended Mar 31, 2023 | May 12, 2023after the close | – | – | -$2.06 | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 29, 2023after the close | – | – | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 14, 2022after the close | – | – | -$0.18 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 11, 2022after the close | – | – | -$0.19 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 12, 2022after the close | – | – | -$0.20 | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 23, 2022after the close | – | – | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 12, 2021before the open | – | – | -$0.19 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 16, 2021after the close | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 14, 2021after the close | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Mar 24, 2021after the close | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 6, 2020after the close | – | – | – | Filing |
| Q2 FY2020ended Jun 30, 2020 | Aug 10, 2020after the close | – | – | – | Filing |
| Q1 FY2020ended Mar 31, 2020 | May 11, 2020after the close | – | – | – | Filing |
| Q4 FY2019ended Dec 31, 2019 | Mar 16, 2020after the close | – | – | – | Filing |
| Q3 FY2019ended Sep 30, 2019 | Nov 12, 2019before the open | – | – | – | Filing |
| Q2 FY2019ended Jun 30, 2019 | Aug 9, 2019after the close | – | – | – | Filing |
| Q1 FY2019ended Mar 31, 2019 | May 10, 2019before the open | – | – | – | Filing |
| Q4 FY2018ended Dec 31, 2018 | Mar 18, 2019after the close | – | – | – | Filing |
| Q3 FY2018ended Sep 30, 2018 | Nov 14, 2018after the close | – | – | – | Filing |
| Q2 FY2018ended Jun 30, 2018 | Aug 13, 2018after the close | – | – | – | Filing |
| Q1 FY2018ended Mar 31, 2018 | May 15, 2018after the close | – | – | – | Filing |
| Q4 FY2017ended Dec 31, 2017 | Mar 29, 2018after the close | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Mustang Bio has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Mustang Bio puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Mustang Bio filed with the SEC as exhibits to Form 8-K or 6-K
- News
- News
- News
- News
- News
- News
- News
- News
- News
- News
- News
- News
- Results
- News
- Results
See a number that looks wrong?